Carregant...

Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer

Basal-like breast cancer is an aggressive disease with limited therapeutic options because these tumors frequently express the ‘triple-negative’ phenotype. We have recently reported that inducible nitric oxide synthase (NOS2) is a strong predictor of survival in patients with estrogen receptor negat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Switzer, Christopher H., Glynn, Sharon A., Ridnour, Lisa A., Cheng, Robert Y.-S., Vitek, Michael P., Ambs, Stefan, Wink, David A.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3380363/
https://ncbi.nlm.nih.gov/pubmed/21893353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2011.07.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!